compliance issues reimbursing glp-1 weight loss treatments multiple states

compliance issues reimbursing glp-1 weight loss treatments multiple states The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs GLP-1 RA Adherence Shows Drop-Off

Name: compliance issues reimbursing glp-1 weight loss treatments multiple states The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs GLP-1 RA Adherence Shows Drop-Off
Brand: actil.am
SKU: 73595242156
Price: 24.23 USD
Availability: InStock
Rating: 4.6867 (8 reviews)

SKU: 73595242156

4.7

USD24.23 USD72.23

Pay in 4 interest-free payments of $6.06 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

GLP-1 drugs slow digestion, causing people to feel fuller longer

[13] These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added

10.1172/JCI42894 J